Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 1
2010 2
2011 3
2012 3
2013 1
2014 3
2015 2
2016 5
2017 11
2018 7
2019 9
2020 12
2021 8
2022 8
2023 15
2024 15
2025 14

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

102 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of vutrisiran for patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy: a randomized clinical trial.
Adams D, Tournev IL, Taylor MS, Coelho T, Planté-Bordeneuve V, Berk JL, González-Duarte A, Gillmore JD, Low SC, Sekijima Y, Obici L, Chen C, Badri P, Arum SM, Vest J, Polydefkis M; HELIOS-A Collaborators. Adams D, et al. Amyloid. 2023 Mar;30(1):1-9. doi: 10.1080/13506129.2022.2091985. Epub 2022 Jul 23. Amyloid. 2023. PMID: 35875890 Free article. Clinical Trial.
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study.
Adams D, Polydefkis M, González-Duarte A, Wixner J, Kristen AV, Schmidt HH, Berk JL, Losada López IA, Dispenzieri A, Quan D, Conceição IM, Slama MS, Gillmore JD, Kyriakides T, Ajroud-Driss S, Waddington-Cruz M, Mezei MM, Planté-Bordeneuve V, Attarian S, Mauricio E, Brannagan TH 3rd, Ueda M, Aldinc E, Wang JJ, White MT, Vest J, Berber E, Sweetser MT, Coelho T; patisiran Global OLE study group. Adams D, et al. Lancet Neurol. 2021 Jan;20(1):49-59. doi: 10.1016/S1474-4422(20)30368-9. Epub 2020 Nov 16. Lancet Neurol. 2021. PMID: 33212063 Free article. Clinical Trial.
Low remission rates and high incidence of adverse events in a prospective VEXAS syndrome registry.
Kirino Y, Maeda A, Asano T, Migita K, Hidaka Y, Ida H, Kobayashi D, Oda N, Rokutanda R, Fujieda Y, Atsumi T, Kishida D, Kobayashi H, Shiratsuchi M, Shimizu T, Kawakami A, Tanaka K, Tsuji T, Mishima K, Miyamae T, Hasegawa A, Ikeda K, Watanabe T, Yamaguchi Y, Nishikomori R, Ohara O, Nakajima H; Japan VEXAS Study Group. Kirino Y, et al. Among authors: kishida d. Rheumatology (Oxford). 2025 Jun 1;64(6):3872-3878. doi: 10.1093/rheumatology/keae530. Rheumatology (Oxford). 2025. PMID: 39340799
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Mar 1;82(3):228-236. doi: 10.1001/jamaneurol.2024.4631. JAMA Neurol. 2025. PMID: 39804640 Free PMC article. Clinical Trial.
Clinical characteristics and treatment strategies for A20 haploinsufficiency in Japan: a national epidemiological survey.
Shiraki M, Kadowaki S, Miwa Y, Nishimura K, Maruyama Y, Kishida D, Imagawa K, Kobayashi C, Takada H, Mitsunaga K, Inoue Y, Ebato T, Miyamoto T, Hiejima E, Sato S, Migita K, Matsubayashi T, Kobayashi D, Hasegawa E, Kaneko U, Ishikawa T, Onodera M, Matsushita K, Koike Y, Umebayashi H, Kakuta F, Abukawa D, Funakoshi Y, Ishimura M, Otani Y, Nishizawa T, Ishige T, Hatori R, Tanaka S, Kusunoki S, Nakamura K, Shirai H, Hatai Y, Miyaoka F, Kaneko S, Shimbo A, Shimizu M, Kanegane H, Hashimoto M, Negoro N, Yoshida T, Wada Y, Usami M, Wada T, Izawa K, Yasumi T, Nishikomori R, Ohnishi H. Shiraki M, et al. Among authors: kishida d. Front Immunol. 2025 Jun 12;16:1548042. doi: 10.3389/fimmu.2025.1548042. eCollection 2025. Front Immunol. 2025. PMID: 40574834 Free PMC article.
Takayasu arteritis complicated by SAPHO syndrome: A case-based review.
Sugimoto S, Kishida D, Kobayashi T, Tanomogi N, Kurashina JI, Ichikawa T, Shimojima Y, Sekijima Y. Sugimoto S, et al. Among authors: kishida d. Clin Rheumatol. 2025 Jul;44(7):3083-3089. doi: 10.1007/s10067-025-07501-0. Epub 2025 May 22. Clin Rheumatol. 2025. PMID: 40404944 Free PMC article. Review.
Verification of unmet medical needs in patients with juvenile idiopathic arthritis in Japan.
Shimizu M, Inoue E, Sakai R, Inoue Y, Mitsunaga K, Sugihara T, Hirano T, Izawa K, Kishida D, Matsushita M, Mori M, Narazaki H, Nishikomori R, Sumitomo S, Tanaka T, Yamazaki S, Yamaji K, Yokogawa N, Yoshifuji H, Miyamae T. Shimizu M, et al. Among authors: kishida d. Mod Rheumatol. 2025 Sep 2;35(5):909-915. doi: 10.1093/mr/roaf032. Mod Rheumatol. 2025. PMID: 40160024
102 results